The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study
IntroductionMurine tumor growth restriction by neem leaf glycoprotein (NLGP) was established in various transplanted models of murine sarcoma, melanoma and carcinoma. However, the role of NLGP in the sequential carcinogenic steps has not been explored. Thus, tongue carcinogenesis in Swiss mice was i...
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1325161/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1846164245232746496 |
---|---|
author | Juhina Das Saurav Bera Nilanjan Ganguly Ipsita Guha Tithi Ghosh Halder Avishek Bhuniya Partha Nandi Mohona Chakravarti Sukanya Dhar Anirban Sarkar Tapasi Das Saptak Banerjee Sandip Ghose Anamika Bose Anamika Bose Rathindranath Baral |
author_facet | Juhina Das Saurav Bera Nilanjan Ganguly Ipsita Guha Tithi Ghosh Halder Avishek Bhuniya Partha Nandi Mohona Chakravarti Sukanya Dhar Anirban Sarkar Tapasi Das Saptak Banerjee Sandip Ghose Anamika Bose Anamika Bose Rathindranath Baral |
author_sort | Juhina Das |
collection | DOAJ |
description | IntroductionMurine tumor growth restriction by neem leaf glycoprotein (NLGP) was established in various transplanted models of murine sarcoma, melanoma and carcinoma. However, the role of NLGP in the sequential carcinogenic steps has not been explored. Thus, tongue carcinogenesis in Swiss mice was induced by 4-nitroquinoline-1-oxide (4NQO), which has close resemblance to human carcinogenesis process. Interventional role of NLGP in initiation-promotion protocol established during 4NQO mediated tongue carcinogenesis in relation to systemic immune alteration and epithelial-mesenchymal transition (EMT) is investigated.Methods4NQO was painted on tongue of Swiss mice every third day at a dose of 25µl of 5mg/ml stock solution. After three consecutive treatments with 4NQO (starting Day7), one group of mice was treated with NLGP (s.c. 25μg/mice/week), keeping a group as PBS control. Mice were sacrificed in different time-intervals to harvest tongues and studied using histology, immunohistochemistry, flow-cytometry and RT-PCR on different immune cells and EMT markers (e-cadherin, vimentin) to elucidate their phenotypic and secretory status.ResultsLocal administration of 4NQO for consecutive 300 days promotes significant alteration in tongue mucosa including erosion in papillae and migration of malignant epithelial cells to the underlying connective tissue stroma with the formation of cell nests (exophytic-hyperkeratosis with mild dysplasia). Therapeutic NLGP treatment delayed pre-neoplastic changes promoting normalization of mucosa by maintaining normal structure. Flow-cytometric evidences suggest that NLGP treatment upregulated CD8+, IFNγ+, granzyme B+, CD11c+ cells in comparison to 4NQO treated mice with a decrease in Ki67+ and CD4+FoxP3+ cells in NLGP treated cohort. RT-PCR demonstrated a marked reduction of MMP9, IL-6, IL-2, CD31 and an upregulation in CCR5 in tongues from 4NQO+NLGP treated mice in comparison to 4NQO treated group. Moreover, 4NQO mediated changes were associated with reduction of e-cadherin and simultaneous up-regulation of vimentin expression in epithelium that was partially reversed by NLGP.DiscussionEfficacy of NLGP was tested first time in sequential carcinogenesis model and proved effective in delaying the initial progression. NLGP normalizes type 1 immunity including activation of the CD8+T effector functions, reduction of regulatory T cell functions, along with changes in EMT to make the host systemically alert to combat the carcinogenic threat. |
format | Article |
id | doaj-art-135df3f8dc1c4a1a8b7e8e4a38eabc10 |
institution | Kabale University |
issn | 1664-3224 |
language | English |
publishDate | 2024-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj-art-135df3f8dc1c4a1a8b7e8e4a38eabc102024-11-18T10:58:24ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-03-011510.3389/fimmu.2024.13251611325161The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical studyJuhina Das0Saurav Bera1Nilanjan Ganguly2Ipsita Guha3Tithi Ghosh Halder4Avishek Bhuniya5Partha Nandi6Mohona Chakravarti7Sukanya Dhar8Anirban Sarkar9Tapasi Das10Saptak Banerjee11Sandip Ghose12Anamika Bose13Anamika Bose14Rathindranath Baral15Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Oral Pathology, Dr. R. Ahmed Dental College and Hospital, Kolkata, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaDepartment of Pharmaceutical Technology (Biotechnology), National Institute of Pharmaceutical Education and Research (NIPER), Sahibzada Ajit Singh Nagar, Punjab, IndiaDepartment of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, IndiaIntroductionMurine tumor growth restriction by neem leaf glycoprotein (NLGP) was established in various transplanted models of murine sarcoma, melanoma and carcinoma. However, the role of NLGP in the sequential carcinogenic steps has not been explored. Thus, tongue carcinogenesis in Swiss mice was induced by 4-nitroquinoline-1-oxide (4NQO), which has close resemblance to human carcinogenesis process. Interventional role of NLGP in initiation-promotion protocol established during 4NQO mediated tongue carcinogenesis in relation to systemic immune alteration and epithelial-mesenchymal transition (EMT) is investigated.Methods4NQO was painted on tongue of Swiss mice every third day at a dose of 25µl of 5mg/ml stock solution. After three consecutive treatments with 4NQO (starting Day7), one group of mice was treated with NLGP (s.c. 25μg/mice/week), keeping a group as PBS control. Mice were sacrificed in different time-intervals to harvest tongues and studied using histology, immunohistochemistry, flow-cytometry and RT-PCR on different immune cells and EMT markers (e-cadherin, vimentin) to elucidate their phenotypic and secretory status.ResultsLocal administration of 4NQO for consecutive 300 days promotes significant alteration in tongue mucosa including erosion in papillae and migration of malignant epithelial cells to the underlying connective tissue stroma with the formation of cell nests (exophytic-hyperkeratosis with mild dysplasia). Therapeutic NLGP treatment delayed pre-neoplastic changes promoting normalization of mucosa by maintaining normal structure. Flow-cytometric evidences suggest that NLGP treatment upregulated CD8+, IFNγ+, granzyme B+, CD11c+ cells in comparison to 4NQO treated mice with a decrease in Ki67+ and CD4+FoxP3+ cells in NLGP treated cohort. RT-PCR demonstrated a marked reduction of MMP9, IL-6, IL-2, CD31 and an upregulation in CCR5 in tongues from 4NQO+NLGP treated mice in comparison to 4NQO treated group. Moreover, 4NQO mediated changes were associated with reduction of e-cadherin and simultaneous up-regulation of vimentin expression in epithelium that was partially reversed by NLGP.DiscussionEfficacy of NLGP was tested first time in sequential carcinogenesis model and proved effective in delaying the initial progression. NLGP normalizes type 1 immunity including activation of the CD8+T effector functions, reduction of regulatory T cell functions, along with changes in EMT to make the host systemically alert to combat the carcinogenic threat.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1325161/full4NQOCD8+ T cellsimmunotherapeuticsneem leaf glycoproteinNotch1oral carcinogenesis |
spellingShingle | Juhina Das Saurav Bera Nilanjan Ganguly Ipsita Guha Tithi Ghosh Halder Avishek Bhuniya Partha Nandi Mohona Chakravarti Sukanya Dhar Anirban Sarkar Tapasi Das Saptak Banerjee Sandip Ghose Anamika Bose Anamika Bose Rathindranath Baral The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study Frontiers in Immunology 4NQO CD8+ T cells immunotherapeutics neem leaf glycoprotein Notch1 oral carcinogenesis |
title | The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study |
title_full | The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study |
title_fullStr | The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study |
title_full_unstemmed | The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study |
title_short | The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study |
title_sort | immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4nqo induced murine oral carcinogenesis a preclinical study |
topic | 4NQO CD8+ T cells immunotherapeutics neem leaf glycoprotein Notch1 oral carcinogenesis |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1325161/full |
work_keys_str_mv | AT juhinadas theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT sauravbera theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT nilanjanganguly theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT ipsitaguha theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT tithighoshhalder theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT avishekbhuniya theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT parthanandi theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT mohonachakravarti theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT sukanyadhar theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT anirbansarkar theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT tapasidas theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT saptakbanerjee theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT sandipghose theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT anamikabose theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT anamikabose theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT rathindranathbaral theimmunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT juhinadas immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT sauravbera immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT nilanjanganguly immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT ipsitaguha immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT tithighoshhalder immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT avishekbhuniya immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT parthanandi immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT mohonachakravarti immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT sukanyadhar immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT anirbansarkar immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT tapasidas immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT saptakbanerjee immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT sandipghose immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT anamikabose immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT anamikabose immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy AT rathindranathbaral immunomodulatoryimpactofnaturallyderivedneemleafglycoproteinontheinitiationprogressionmodelof4nqoinducedmurineoralcarcinogenesisapreclinicalstudy |